Study finds opioids not helpful in treating chronic pain

9 December 2016
marketreportbig

A new study maintains that the use of opioid therapy to treat chronic pain is not only ineffective, it can actually increase the likelihood of more harmful consequences, including death.

Palliative care physicians Mellar Davis and Zankhana Mehta authored the Geisinger Health System study which provides a review of the current research on chronic opioid therapy. The study was published in the December 2016 edition of Current Oncology Reports.

"When patients are given opioid therapy for chronic pain, there is evidence that it interferes with the body's natural resolution of the pain," said Dr Davis, who co-chaired the 2015 International Conference on Opioids at Harvard Medical School. "Opioid therapy may put someone at an increased risk for multiple adverse effects. And it actually has the potential of extending the history of their pain," he noted.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical